Tumour necrosis factor alpha and oxidative stress as maintaining factors in the evolution of anorexia nervosa

  • E. Agnello
  • G. Malfi
  • A. M. Costantino
  • P. Massarenti
  • M. Pugliese
  • N. Fortunati
  • M. G. Catalano
  • A. Palmo
Original Research Paper


OBJECTIVE: Aim of the study was to evaluate tumour necrosis factor α (TNF-α) axis and oxidative status in patients with anorexia nervosa (AN) seeking a possible correlation with both nutritional status and evolution of the disease. SUBJECTS AND METHODS: Thirty-nine consecutive women with AN and an age-matched healthy control group were studied. Patients were 26±9 yr, with a body mass index (BMI) of 13.9±2 kg/m2. TNF-α, its receptors TNF-R55 and TNF-R75, and oxidative status markers (selenium, ascorbic/dehydroascorbic acid, retinol, α-tocopherol, selenium-dependent gluthatione peroxidase, reduced/oxidated gluthatione) were measured. A correlation with both nutritional indexes (body weight, BMI, albumin, prealbumin, transferrin, lymphocyte count) and disease duration was investigated. Pearson’s correlation and unpaired Student’s t-test were used to compare patients and controls. RESULTS: TNF-α and oxidative status markers were significantly higher in patients than controls and TNF-α was directly related to dehydroascorbic acid (p<0.05). Both TNF-R55 and TNF-R75 were higher in patients with duration of disease longer than one year as compared to controls and patients with shorter duration. Receptors inversely correlated with BMI (p<0.05 and p<0.01) and directly with disease duration (p<0.05). Inverse correlation between disease duration and BMI was present (p<0.01). CONCLUSIONS: The study showed activation of TNF-α axis and oxidative stress in AN patients, as well as correlation between the two systems. Due to the correlation between TNF receptors and both BMI and disease duration, a possible role of pro-inflammatory cytokines in the evolution of the eating disorder is suggested.


Anorexia nervosa oxidative stress pro-inflammatory cytokines TNF-α TNF-R55 TNF-R75 


  1. 1.
    Langstein HN, Norton JA. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991; 5: 103–23.PubMedGoogle Scholar
  2. 2.
    Holden RJ, Pakula IS. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses 1996; 47: 423–38.PubMedCrossRefGoogle Scholar
  3. 3.
    Brambilla F, Bellodi L, Brunetta M, et al. Plasma concentrations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in anorexia and bulimia nervosa. Psychoneroendocrinology 1998; 23 (Suppl 5): 439–47.CrossRefGoogle Scholar
  4. 4.
    Pomeroy C, Eckert E, Hu S, et.al. Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa. Biol Psychiatry 1994; 36: 836–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Nakai Y, Hamagaky S, Kato S, et al. Role of leptin in women with eating disorders. Int J Eat Disord 1999; 26 (Suppl 1): 29–35.PubMedCrossRefGoogle Scholar
  6. 6.
    Limone P, Biglino A, Bottino F, et al. Evidence for a positive correlation between cortisol levels and IL-1 beta production by peripheral mononuclear cells in anorexia nervosa. J Endocrinol Invest 2000; 23: 422–7.PubMedGoogle Scholar
  7. 7.
    Corcos M, Guilbaud O, Chaouat G, et al. Cytokines and anorexia nervosa. Psychosom Med 2001; 63: 502–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Vaisman N, Hahn T, Karov Y, et al. Changes in cytokine production and impaired hematopoiesis in patients with anorexia nervosa: the effect of refeeding. Cytokine 2004; 26: 255–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Kahl KG, Kruse N, Rieckmann P, et al. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychoneuroendocrinology 2004; 29: 13–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Ahrén-Moonga J, Lekander M, von Blixen N, et al. Levels of tumor necrosis factor-alpha and interleukin-6 in severely ill patients with eating disorders. Neuropshycobiology 2011; 63 (Suppl 1): 8–14.CrossRefGoogle Scholar
  11. 11.
    Vaisman N, Hahn T. Tumor necrosis factor-alpha and anorexia — cause or effect? Metabolism 1991; 40: 720–3.PubMedCrossRefGoogle Scholar
  12. 12.
    Raymond NC, Dysken M, Bettin K, et al. Cytokines and anorexia nervosa, bulimia nervosa and obesity. Int J Eat Disord 2000; 28: 293–302.PubMedCrossRefGoogle Scholar
  13. 13.
    Brambilla F, Monti D, Franceschi C. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa. Psychiatry Res 2001; 103: 107–14.PubMedCrossRefGoogle Scholar
  14. 14.
    Nova E, Gómez-Martínez S, Morandé G, et al. Cytokine production by blood mononuclear cells from inpatients with anorexia nervosa. Br J Nutr 2002; 88: 183–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Nogueira JP, Maraninchi M, Lorec AM, et al. Specific adipocytokines profiles in patients with hyperactive and/or binge/purge form of anorexia nervosa. Eu J Clin Nutr 2010; 64: 840–4.CrossRefGoogle Scholar
  16. 16.
    Grimble RF. Nutritional modulation of cytokine biology. Nutrition 1998; 14: 634–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Moyano D, Sierra C, Brandi N, et al. Antioxidant status in anorexia nervosa. Int J Eat Disord 1999; 25: 99–103.PubMedCrossRefGoogle Scholar
  18. 18.
    Sofic E, Rustembegovic A, Kroyer G, et al. Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm 2002; 109: 711–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Tajiri K, Shimizu Y, Tsuneyama K, et al. A case report of oxidative stress in a patient with anorexia nervosa. Int J Eat Disord 2006; 39: 616–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Rodrigues Pereira N, Bandeira Moss M, Assumpção CR, et al. Oxidative stress, L-arginine-nitric oxide and arginase pathways in platelets from adolescents with anorexia nervosa. Blood cells Mol Dis 2010; 44: 164–8.PubMedCrossRefGoogle Scholar
  21. 21.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994.Google Scholar
  22. 22.
    Harapanhalli RS, Howell RW, Rao DV. Testicular and plasma ascorbic acid levels in mice following dietary intake: a high-performance liquid chromatographic analysis. J Chromatogr 1993; 614: 233–43.PubMedCrossRefGoogle Scholar
  23. 23.
    Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–69.PubMedGoogle Scholar
  24. 24.
    Cereser C, Guichard J, Drai J, et al. Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts. J Chromatogr B Biomed Sci Appl 2001; 752: 123–32.PubMedCrossRefGoogle Scholar
  25. 25.
    Corcos M, Guilbaud O, Paterniti S, et al. Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology 2003; 28: 229–49.PubMedCrossRefGoogle Scholar
  26. 26.
    Goebel MU, Mills PJ, Irwin MR, et al. Interleukine-6 and tumor necrosis factor production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom Med 2000; 62: 591–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Schiller JH, Storer BE, Witt PL, et al. Biological and clinical effects of intravenous tumor necrosis factoralpha administrated three times weekly. Cancer Res 1991; 51: 1651–8.PubMedGoogle Scholar
  28. 28.
    Dantzer R, Bluthé RM, Kent S et al. Behavioral effects of cytokine: an insight into mechanisms of sickness behavior. In: De Souza E (Ed). Methods in neuroscience. Orlando, FL, Academic Press, 1993, pp 130–49.Google Scholar
  29. 29.
    Holden RJ, Pakula IS. Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa? Med Hypotheses 1999; 52: 156–62.Google Scholar
  30. 30.
    Himmerich H, Fulda S, Linseisen J, et al. Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 2008; 23: 421–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Vaisman N, Barak Y, Hahn T, et al. Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatr Res 1996; 40: 108–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157: 683–94.PubMedCrossRefGoogle Scholar
  33. 33.
    Van Binsbergen CJ, Odink J, Van den Berg H, et al. Nutritional status in anorexia nervosa: clinical chemistry, vitamins, iron and zinc. Eur J Clin Nutr 1988; 42: 929–37.PubMedGoogle Scholar
  34. 34.
    Rock CL, Vasantharajan S. Vitamin status of eating disorder patients: relationship to clinical indices and effect of tratment. Int J Eat Disord 1995; 18 (Suppl 3): 257–62.PubMedCrossRefGoogle Scholar

Copyright information

© Editrice Kurtis 2012

Authors and Affiliations

  • E. Agnello
    • 1
  • G. Malfi
    • 1
  • A. M. Costantino
    • 1
  • P. Massarenti
    • 2
  • M. Pugliese
    • 3
  • N. Fortunati
    • 4
  • M. G. Catalano
    • 3
  • A. Palmo
    • 1
  1. 1.A.O.U. San Giovanni Battista of TurinTurinItaly
  2. 2.Laboratory of Clinical NutritionA.O.U. San Giovanni Battista of TurinTurinItaly
  3. 3.Department of Clinical PathophysiologyUniversity of TurinTurinItaly
  4. 4.Laboratory of Oncological EndocrinologyA.O.U. San Giovanni Battista of TurinTurinItaly

Personalised recommendations